In the same regard, Kim et al. demonstrated that recurring intrathecal (I.T.)administration of human UCB-MSCs improves adult hippocampal neurogenesis and synaptic activity through growth differentiation factor-15 (GDF-15) secretion in an AD model [36]. This evidence concerns the gene GDF15 and Alzheimer disease.